-
Je něco špatně v tomto záznamu ?
Significance of plasma fibrinogen and malondialdehyde in the post-inflammatory period in patients with cystic fibrosis
Ondrej Hloch, Libor Fila, Jan Havlin, Jiri Charvat, Sabina Palova
Jazyk angličtina Země Slovensko
Typ dokumentu práce podpořená grantem, hodnotící studie, klinická studie
- MeSH
- biologické markery * krev MeSH
- cystická fibróza * krev MeSH
- dechový objem MeSH
- dospělí MeSH
- fibrinogen analýza MeSH
- klinické zhoršení MeSH
- korelace dat MeSH
- lidé MeSH
- malondialdehyd analýza MeSH
- prognóza MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- hodnotící studie MeSH
- klinická studie MeSH
- práce podpořená grantem MeSH
OBJECTIVES: Evaluation of selected inflammatory parameters and serum malondialdehyde (MDA) significance in the post-inflammatory period in adult patients with cystic fibrosis. BACKGROUND: Laboratory biomarkers can be integrated into clinical practice as part of monitoring the effectiveness of treatment. METHODS: After recovery from an acute exacerbation of lung infection, selected inflammatory parameters (fibrinogen, IL-1, IL-6, SAA, hs-CRP) and serum MDA were examined in 30 adult patients with cystic fibrosis. Their correlation with FEV1, frequency and duration of subsequent hospitalizations and 6-year prognosis in terms of mortality or need for lung transplantation was evaluated. RESULTS: FEV1 negatively correlated with fibrinogen, but positively with MDA. No significant correlation with hs-CRP, IL-1, IL-6 and SAA was recorded. Plasma fibrinogen predicted the frequency and duration of subsequent hospitalizations. The 6-year prognosis was negatively associated with plasma fibrinogen whereas its association with MDA was positive. However, the prognosis of patients in the multivariate analysis was significantly associated only with FEV1. CONCLUSION: Plasma fibrinogen examined in the post-inflammatory period is a marker of lung damage in patients with cystic fibrosis and can be used to predict the prognosis. The positive correlation of serum MDA with FEV1 in the post-inflammatory period may be important to the interpretation of treatment interventions (Tab. 3, Fig. 2, Ref. 17).
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22026099
- 003
- CZ-PrNML
- 005
- 20230110133813.0
- 007
- ta
- 008
- 221102s2022 xo d fs 000 0|eng||
- 009
- AR
- 024 0_
- $a 10.4149/BLL_2022_025 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Hloch, Ondřej $7 xx0175745 $u Department of Internal Medicine and Department of Pneumology, 2nd Faculty Medicine of Charles University and Faculty Hospital Prague Motol, Prague, Czech Republic
- 245 10
- $a Significance of plasma fibrinogen and malondialdehyde in the post-inflammatory period in patients with cystic fibrosis / $c Ondrej Hloch, Libor Fila, Jan Havlin, Jiri Charvat, Sabina Palova
- 504 __
- $a Literatura
- 520 9_
- $a OBJECTIVES: Evaluation of selected inflammatory parameters and serum malondialdehyde (MDA) significance in the post-inflammatory period in adult patients with cystic fibrosis. BACKGROUND: Laboratory biomarkers can be integrated into clinical practice as part of monitoring the effectiveness of treatment. METHODS: After recovery from an acute exacerbation of lung infection, selected inflammatory parameters (fibrinogen, IL-1, IL-6, SAA, hs-CRP) and serum MDA were examined in 30 adult patients with cystic fibrosis. Their correlation with FEV1, frequency and duration of subsequent hospitalizations and 6-year prognosis in terms of mortality or need for lung transplantation was evaluated. RESULTS: FEV1 negatively correlated with fibrinogen, but positively with MDA. No significant correlation with hs-CRP, IL-1, IL-6 and SAA was recorded. Plasma fibrinogen predicted the frequency and duration of subsequent hospitalizations. The 6-year prognosis was negatively associated with plasma fibrinogen whereas its association with MDA was positive. However, the prognosis of patients in the multivariate analysis was significantly associated only with FEV1. CONCLUSION: Plasma fibrinogen examined in the post-inflammatory period is a marker of lung damage in patients with cystic fibrosis and can be used to predict the prognosis. The positive correlation of serum MDA with FEV1 in the post-inflammatory period may be important to the interpretation of treatment interventions (Tab. 3, Fig. 2, Ref. 17).
- 650 _7
- $a dospělí $7 D000328 $2 czmesh
- 650 _7
- $a ženské pohlaví $7 D005260 $2 czmesh
- 650 _7
- $a lidé $7 D006801 $2 czmesh
- 650 _7
- $a mužské pohlaví $7 D008297 $2 czmesh
- 650 _7
- $a fibrinogen $x analýza $7 D005340 $2 czmesh
- 650 _7
- $a malondialdehyd $x analýza $7 D008315 $2 czmesh
- 650 17
- $a cystická fibróza $x krev $7 D003550 $2 czmesh
- 650 17
- $a biologické markery $x krev $7 D015415 $2 czmesh
- 650 _7
- $a dechový objem $7 D013990 $2 czmesh
- 650 _7
- $a prognóza $7 D011379 $2 czmesh
- 650 _7
- $a korelace dat $7 D000078331 $2 czmesh
- 650 _7
- $a klinické zhoršení $7 D000075902 $2 czmesh
- 655 _7
- $a práce podpořená grantem $7 D013485 $2 czmesh
- 655 _7
- $a hodnotící studie $7 D023362 $2 czmesh
- 655 _7
- $a klinická studie $7 D000068397 $2 czmesh
- 700 1_
- $a Fila, Libor, $d 1968- $7 ola2006345307 $u Department of Internal Medicine and Department of Pneumology, 2nd Faculty Medicine of Charles University and Faculty Hospital Prague Motol, Prague, Czech Republic
- 700 1_
- $a Havlín, Jan $7 xx0093656 $u 3rd Department of Surgery, 1st Faculty of Medicine of Charles University and Faculty Hospital Prague Motol, Czech Republic
- 700 1_
- $a Charvát, Jiří, $d 1948- $7 pna2005261832 $u Department of Internal Medicine and Department of Pneumology, 2nd Faculty Medicine of Charles University and Faculty Hospital Prague Motol, Prague, Czech Republic
- 700 1_
- $a Pálová, Sabina $7 xx0128164 $u Department of Internal Medicine and Department of Pneumology, 2nd Faculty Medicine of Charles University and Faculty Hospital Prague Motol, Prague, Czech Republic
- 773 0_
- $t Bratislavské lekárske listy $x 0006-9248 $g Roč. 123, č. 3 (2022), s. 149-152 $w MED00000845
- 856 41
- $u http://www.elis.sk/download_file.php?product_id=7576&session_id=5hob67buame1h4jbqk1qin6737 $y plný text volně přístupný
- 910 __
- $a ABA008 $b online $c 1067 $y p $z 0
- 990 __
- $a 20221101161338 $b ABA008
- 991 __
- $a 20230110133810 $b ABA008
- 999 __
- $a ok $b bmc $g 1855743 $s 1177403
- BAS __
- $a 3
- BMC __
- $a 2022 $b 123 $c 3 $d 149-152 $i 0006-9248 $m Bratislavské lekárske listy $x MED00000845
- LZP __
- $c NLK189 $d 20221217 $a NLK 2022-22/kv